Job Title: Junior Scientist – Applications Team
Reports to: Applications Manager
Job location: Xampla HQ, Cambridge Science Park (on-site)
Introduction to Xampla
Xampla is a groundbreaking materials technology company unlocking the power of natural plant polymers for a range of industries and applications, from plastic-free alternatives in packaging to high-performance encapsulation.
London & Copenhagen, July 8, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Biomia and is pleased to announce the placement of Frederick Westhorpe, PhD as Chief Scientific Officer (CSO).
At the forefront of immunotherapy innovation, Creative Biolabs boasts a next-generation custom CAR design and construction platform that allows researchers to create highly specific chimeric antigen receptors for various targets and applications. From streamlining signal domains to selecting best-fit backbones for vectors, their platform is designed for flexibility, precision, and velocity.
Three bite-sized talks await, along with games, prizes, food, and fun!
Join us for a cell analysis lunch and learn to discover innovations in plate readers, Luminex technology and flow cytometry!
Introducing the Luminex platform and the power of multiplexing
Save time, sample load and cost with the Luminex assays enabling protein and gene mutliplexing. Omit intra-assay variability and numerous pain points of conventional protein and genetic workflows. Come an learn how this technology can be a game changer to your research.
Applications are invited for an Alliance and Impact Officer (SC6) or Alliance and Impact Manager (SC5) to join the Knowledge Exchange and Commercialisation Team at Quadram Institute Bioscience (QIB), based in Norwich, UK.
Background:
Why Attend?
Over 350 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, are expected to get together in London next April for the 22nd Annual Anglonordic Life Science Conference.
*One Nucleus members receive 10% discount off registration. Please contact [email protected] for a code.
Who we are:
Life, Reimagined
Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
As part of our commitment to enabling member success and sharing best practices from peers, One Nucleus hosted a roundtable bringing together procurement and legal experts. What emerged from these discussions was a clear understanding that procurement can significantly impact your investor story, making it an extremely valuable lever for growth.
Who we are:
Life, Reimagined
Constructive Bio is a VC-backed biotechnology start-up based in Whittlesford, Cambridge. Our breakthrough technology harnesses the power of genome rewriting and genetic code reprogramming to make valuable products that positively impact the world. We will use our platform to turn cells into bio-renewable factories to produce novel molecules that were previously inaccessible to natural biology, with diverse applications in industries spanning healthcare, biological research, materials and electronics.
Who we are:
Life, Reimagined